DekaBank Deutsche Girozentrale
NEOS

DekaBank Deutsche Girozentrale’s Neos Therapeutics, Inc NEOS Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-7,500
Closed -$77K – 1072
2016
Q1 		$77K Buy
+7,500
New +$79.1K ﹤0.01% 997

Other funds holding NEOS

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return

DekaBank Deutsche Girozentrale's NEOS Position: Q2 2016 in Review

DekaBank Deutsche Girozentrale sold out of Neos Therapeutics, Inc (NEOS) in Q2 2016, closing a stake of 7,500 shares — an estimated $77K sold.

DekaBank Deutsche Girozentrale first reported a position in NEOS in Q1 2016 and held it in 1 quarter. The position peaked at $77K in Q1 2016. 46 funds tracked by Wall St. Rank hold NEOS as of Q2 2016.

  • DekaBank Deutsche Girozentrale reported no remaining Neos Therapeutics, Inc position as of Q2 2016 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 7,500 Neos Therapeutics, Inc shares in Q2 2016, an estimated $77K.
  • DekaBank Deutsche Girozentrale first reported a position in Neos Therapeutics, Inc in Q1 2016 and held it in 1 quarter.
  • DekaBank Deutsche Girozentrale's Neos Therapeutics, Inc position peaked at $77K in Q1 2016.
  • 46 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q2 2016.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2016, filed 4 Aug 2016.